drugset / Trial / NCT00340379
Ziprasidone vs. Sertraline/Haloperidol in Psychotic Depression
Phase 2/3
Completed
72 enrolled
Duke University
National Institute of Mental Health and Neuro Sciences, India · collabPfizer · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to compare ziprasidone (Geodon) monotherapy for the treatment of psychotic major depression (PMD)with an antidepressant/antipsychotic combined therapy.
Timeline
- Start
- 2003-04
- Primary completion
- 2005-08
- Completion
- 2005-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Haloperidol | Other / unclassified | — | — |
| Comparator | Sertraline | Small molecule | — | — |
| Comparator | Ziprasidone | Small molecule | — | — |